Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD

Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in sto...

Descripción completa

Detalles Bibliográficos
Autores principales: Buderus, Stephan, Boone, James H., Lentze, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458270/
https://www.ncbi.nlm.nih.gov/pubmed/26089872
http://dx.doi.org/10.1155/2015/578527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458270/
https://www.ncbi.nlm.nih.gov/pubmed/26089872
http://dx.doi.org/10.1155/2015/578527

Ejemplares similares